Chronic inflammation's connection to atrial fibrillation points to IL-1β as a promising treatment target
A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...
Seeking Alpha14d
Oklo, Lightbridge sign MoU to explore co-location of commercial fuel fabrication plants
Oklo (NYSE:OKLO) said Tuesday it signed a memorandum of understanding with Lightbridge (LTBR) to conduct a feasibility study to co-locate a Lightbridge commercial-scale fuel fabrication facility ...
Nasdaq14d
Lightbridge Corporation and Oklo Inc. Sign MOU to Explore Collaboration in Nuclear Fuel Fabrication and Recycling
Lightbridge Corporation and Oklo Inc. signed an MOU for feasibility studies on co-locating fuel fabrication facilities and nuclear waste recycling. The reliance on a Memorandum of Understanding ...
Macworld15d
iOS 18.3 is out now, improving Notification Summaries and Visual Intelligence
Apple Intelligence has been the focus of most iOS 18 updates so far, and we’re still waiting on the big Siri overhaul that adds personal context using the data on your phone and scores of new ...
Reuters21d
Beta Bionics targets up to $616 mln valuation in US IPO
Jan 22 (Reuters) - Insulin delivery device maker Beta Bionics said on Wednesday it was targeting a valuation of as much as $615.9 million in its initial public offering in the United States ...
9to5google21d
Android 15 QPR2 Beta 3 rolling out to Pixel
Ahead of the stable launch in March, Google is rolling out Android 15 QPR2 Beta 3 for Pixel devices. Quarterly Platform Releases deliver more significant changes compared to monthly bug fixes.
GamesRadar+22d
How to play the Elden Ring Nightreign beta
Registration for the Elden Ring Nightreign beta closed on January 20, so currently there is no way to sign up for the network test if you haven't done so already. The Elden Ring Nightreign beta ...